Back
Aprea Therapeutics 10K Form
Sell
4
APRE
Aprea Therapeutics
Last Price:
4.06
Seasonality Move:
-16.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APRE News And Ratings
See the #1 stock for the next 7 days that we like better than APRE
APRE Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-3.65M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.71 |
Price / Book: | 0.84 |
Profitability
EPS (TTM): | -3.03000 |
---|---|
Net Income (TTM): | $-12.93M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Aprea Therapeutics Earnings Forecast
Key Aprea Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Aprea Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | APRE |
CUSIP: | 03836J |
Website: | aprea.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
APRE Technical Analysis vs Fundamental Analysis
Sell
4
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy or a Sell?
-
Aprea Therapeutics stock is rated a Sell
The current Aprea Therapeutics [APRE] share price is $3.97. The Score for APRE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.